Library · Heart, blood & kidney · Cardiovascular health support and protection
Cardiogen (Ala-Glu-Asp-Arg)
AEDR peptide, Ala-Glu-Asp-Arg, L-Alanyl-L-glutamyl-L-aspartyl-L-arginine
Synthetic tetrapeptide (Ala-Glu-Asp-Arg) from Russian bioregulator research, intended to support cardiovascular tissue. Studied there without recent international clinical data; not FDA/EMA approved and sold as a research chemical.
Research score 30/100. Reference only, not a dose.
- Cardiovascular Health
- Blood Pressure Regulation
- Cardioprotection
- Anti-inflammatory
- US status
- Research Chemical
- Approval
- Not Approved by FDA/EMA
- Evidence
- Limited to Russian preclinical studies; no human clinical trials have been conducted.
- Research score
- 30 / 100
- Indication
- Research Only - No Medical Indication
- Origin
- Russia
- Source category
- Heart & Cardiovascular
- Status group
- Research chemical
Mechanism
Believed to modulate gene expression in heart cells, encouraging cardiomyocyte growth while limiting fibroblast activity and scarring, boosting structural protein production, and possibly reducing apoptosis via lowered p53 expression.
Safety file
Data is limited; animal studies suggest good tolerability, but no human trials exist, so human safety is unknown.
- Injection site reactions
- Blood pressure fluctuations
- Mild dizziness
- Fatigue